Tangles and plaques in nondemented aging and 'preclinical' alzheimer's disease

Annals of Neurology

Volumn 45, Issue 3, 1999, Pages 358-368

  Price, Joseph L ^a   Morris, John C ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID;

ADULT; AGED; AGING; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DEMENTIA; FEMALE; HUMAN; HUMAN TISSUE; LIMBIC SYSTEM; MAJOR CLINICAL STUDY; MALE; NEOCORTEX; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; SENILE PLAQUE;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN MAPPING; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROFIBRILLARY TANGLES; SENILE PLAQUES;

EID: 0032989712     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X     Document Type: Article

References (29)

1. Brayne C, Gill C, Huppert FA, et al. Incidence of clinically diagnosed subtypes of dementia in an elderly population. Cambridge project for later life. Br J Psychiatry 1995;167:255-262
2. Tomlinson BE, Blessed G, Roth M. Observations on the brains of nondemented old people. J Neurol Sci 1968;7:331-356
3. Crystal H, Dickson D, Fuld P, et al. Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer's disease. Neurology 1988;38:1682-1687
4. Katzman R, Terry R, DeTeresa R, et al. Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Ann Neurol 1988;23:138-144
5. West MJ, Coleman PD, Flood DG, Troncoso JC. Differences in the pattern of hippocampal neuronal loss in normal aging and Alzheimer's disease. Lancet 1994;344:769-772
6. Gomez-Isla T, Price JL, McKeel DW, et al. Profound loss of layer II entorhinal cortex neurons distinguishes very mild Alzheimer's disease from nondemented aging. J Neurosci 1996;16: 4491-4500
7. Rubin EH, Storandt M, Miller JP, et al. A prospective study of cognitive function and onset of dementia in cognitively healthy elders. Arch Neurol 1998;55:395-401
8. Morris JC, McKeel D, Storandt M, et al. Very mild Alzheimer's disease: informant-based clinical, psychometric, and pathological distinction from normal aging. Neurology 1991; 41:469-478
9. Price JL, Davis PB, Morris JC, White DL. The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease. Neurobiol Aging 1991; 12:295-312
10. Morris JC. The Clinical Dementia Rating (CDR). Current version and scoring rules. Neurology 1993;43:2412-2414
11. Morris JC, Storandt M, McKeel DW, et al. Cerebral amyloid deposition and diffuse plaques in "normal" aging: evidence for presymptomatic and very mild Alzheimer's disease. Neurology 1996;46:707-719
12. Rubin EH, Morris JC, Grant EA, Vendegna T. Very mild senile dementia of the Alzheimer type. I. Clinical assessment. Arch Neurol 1989;46:379-382
13. Berg L, McKeel DW, Miller JP, et al. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histological markers to dementia severity, age, sex and APOE genotype. Arch Neurol 1998;55:326-335
14. Arrigada PV, Marzloff K, Hyman B. Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease. Neurology 1992;42: 1681-1688
15. Troncoso JC, Martin LJ, Dal Forno G, Kawas CH. Neuropathology in controls and demented subjects from the Baltimore longitudinal study of aging. Neurobiol Aging 1996;17:365-371
16. Davis PB, White H, Price JL, et al. Retrospective postmortem dementia assessment: validation of a new clinical interview to assist neuropathological study. Arch Neurol 1991;48:613-617
17. Scheuner D, Eckman C, Jensen M, et al. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat Med 1996;2:864-870
18. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-486
19. Mirra SS. The CERAD neuropathology protocol and consensus recommendations for the postmortem diagnosis of Alzheimer's disease: a commentary. Neurobiol Aging 1997;18:S91-S94
20. Braak H, Braak E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging 1997;18:351-357
21. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991;82:239-259
22. Duyckaerts C, Hauw J-J. Prevalence, incidence and duration of Braak's stages in the general population: can we know? Neurobiol Aging 1997;18:362-369
23. Silverman W, Wisniewski HM, Bobinski M, Wegiel J. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging 1997;18:377-379 (Comment)
24. Hyman B, Trojanowski JQ. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. Neurobiol Aging 1997;18:S1-S2
25. Gomez-Isla, T, Price JL, McKeel DW, et al. Hierarchical patterns of neuronal loss in Alzheimer's disease. Soc Neurosci Abstr 1996;22:14 (Abstract)
26. Gomez-Isla T, Hollister R, West H, et al. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann Neurol 1997;41:17-24
27. Poorkaj P, Bird TD, Wijsman E, et al. Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann Neurol 1998;43:815-825
28. Hutton M, Lendon CL, Rizzu P, et al. Association of missence and 5′ splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998;393:702-705
29. Hulette CM, Welsh-Bohmer DA, Murray MG, et al. Neuropathological and neuropsychological changes in "normal" aging: evidence for preclinical Alzheimer disease in cognitively normal individuals. J Neuropathol Exp Neurol 1998;57:1168-1174